


Searching News Database: hysterectomy
HSMN NewsFeed - 13 Aug 2021
Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination
Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination
HSMN NewsFeed - 26 Jun 2017
Channel Medsystems(R) Earns CE Mark Approval for the Cerene(R) Cryotherapy Device
Channel Medsystems(R) Earns CE Mark Approval for the Cerene(R) Cryotherapy Device
HSMN NewsFeed - 14 Feb 2017
TransEnterix Announces First Clinical Use of Senhance(TM) Robotic Surgical System in France
TransEnterix Announces First Clinical Use of Senhance(TM) Robotic Surgical System in France
HSMN NewsFeed - 28 Jun 2016
Halt Medical, Inc. Announces The First Acquisition Of Acessa Guidance System
Halt Medical, Inc. Announces The First Acquisition Of Acessa Guidance System
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 14 Dec 2015
Stryker Introduces New Advanced Imaging Modalities To Minimally Invasive Surgery With The 1588 AIM Platform
Stryker Introduces New Advanced Imaging Modalities To Minimally Invasive Surgery With The 1588 AIM Platform
HSMN NewsFeed - 22 Jan 2014
Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure(TM) Maryland Jaw
Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure(TM) Maryland Jaw
HSMN NewsFeed - 1 May 2012
Teleflex Enters into Definitive Agreement to Acquire Laparoscopic Fascial Closure System
Teleflex Enters into Definitive Agreement to Acquire Laparoscopic Fascial Closure System
HSMN NewsFeed - 27 Feb 2012
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
HSMN NewsFeed - 30 Mar 2011
Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
HSMN NewsFeed - 31 Jan 2011
Boston Scientific Announces FDA Approval of Renegade(R) HI-FLO Fathom(R) Pre-Loaded System
Boston Scientific Announces FDA Approval of Renegade(R) HI-FLO Fathom(R) Pre-Loaded System
HSMN NewsFeed - 6 Jan 2011
Gynesonics Receives the CE-Mark for the VizAblate(TM) System to Treat Uterine Fibroids
Gynesonics Receives the CE-Mark for the VizAblate(TM) System to Treat Uterine Fibroids
HSMN NewsFeed - 21 Jul 2010
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
HSMN NewsFeed - 18 May 2010
Covidien Launches SILS Stitch Suturing Device for Advanced Laparoscopic Surgery
Covidien Launches SILS Stitch Suturing Device for Advanced Laparoscopic Surgery
HSMN NewsFeed - 17 Feb 2010
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
HSMN NewsFeed - 13 Jan 2010
First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
HSMN NewsFeed - 17 Aug 2009
BioSphere Medical Announces New Journal Articles Published Discussing Uterine Fibroid Embolization
BioSphere Medical Announces New Journal Articles Published Discussing Uterine Fibroid Embolization
HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
HSMN NewsFeed - 22 Oct 2007
First-in-Man Single Port Reconstructive Urogynecological Operations Performed at Cleveland Clinic
First-in-Man Single Port Reconstructive Urogynecological Operations Performed at Cleveland Clinic
HSMN NewsFeed - 10 Aug 2007
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
HSMN NewsFeed - 27 Jun 2007
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
HSMN NewsFeed - 14 May 2007
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
HSMN NewsFeed - 7 May 2007
Early Results of the CellCept(R) Spare the Nephron Study Examine Kidney Function
Early Results of the CellCept(R) Spare the Nephron Study Examine Kidney Function
HSMN NewsFeed - 4 Apr 2007
Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding
Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding
HSMN NewsFeed - 1 Mar 2007
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
HSMN NewsFeed - 20 Feb 2007
Bakri Postpartum Balloon Globally Acknowledged for Treatment of Postpartum Bleeding
Bakri Postpartum Balloon Globally Acknowledged for Treatment of Postpartum Bleeding
HSMN NewsFeed - 15 Nov 2006
Eight Studies Evaluating Cytyc's Novasure(R) System Presented at AAGL Meeting
Eight Studies Evaluating Cytyc's Novasure(R) System Presented at AAGL Meeting
HSMN NewsFeed - 26 Oct 2006
Aspreva Pharmaceuticals Announces Preliminary Results of Phase III Trial of CellCept for Myasthenia Gravis
Aspreva Pharmaceuticals Announces Preliminary Results of Phase III Trial of CellCept for Myasthenia Gravis
HSMN NewsFeed - 16 Oct 2006
IP Chemotherapy, Combination Therapy for Cervical Cancer and IVF Treatment for Infertility
IP Chemotherapy, Combination Therapy for Cervical Cancer and IVF Treatment for Infertility
Additional items found! 74
Members Archive contains
74 additional stories matching:
hysterectomy
(Password required)
hysterectomy
(Password required)
